Cerity Partners’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-10,348
| Closed | -$20.6K | – | 2505 |
|
2024
Q3 | $20.6K | Buy |
+10,348
| New | +$20.6K | ﹤0.01% | 2512 |
|
2020
Q4 | – | Sell |
-35,600
| Closed | -$528K | – | 649 |
|
2020
Q3 | $528K | Sell |
35,600
-2,438
| -6% | -$36.2K | 0.02% | 315 |
|
2020
Q2 | $560K | Buy |
38,038
+2,438
| +7% | +$35.9K | 0.03% | 267 |
|
2020
Q1 | $418K | Sell |
35,600
-850
| -2% | -$9.98K | 0.03% | 303 |
|
2019
Q4 | $857K | Buy |
36,450
+1,370
| +4% | +$32.2K | 0.04% | 259 |
|
2019
Q3 | $649K | Buy |
35,080
+10,080
| +40% | +$186K | 0.04% | 284 |
|
2019
Q2 | $465K | Sell |
25,000
-90
| -0.4% | -$1.67K | 0.03% | 330 |
|
2019
Q1 | $613K | Buy |
+25,090
| New | +$613K | 0.04% | 301 |
|